WO1994010328A1 - Process for the isolation and purification of mevinolin - Google Patents
Process for the isolation and purification of mevinolin Download PDFInfo
- Publication number
- WO1994010328A1 WO1994010328A1 PCT/HU1993/000051 HU9300051W WO9410328A1 WO 1994010328 A1 WO1994010328 A1 WO 1994010328A1 HU 9300051 W HU9300051 W HU 9300051W WO 9410328 A1 WO9410328 A1 WO 9410328A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- filtered
- active ingredient
- liquor
- mevinolin
- fermentation liquor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Definitions
- This invention relates to a process for the isolation and purification of mevinolin from fermentation liquor.
- Mevinolin (lovastatin, monacolin K, K 803) is a known antihypercholesterolemic agent, which can be produced by fermentation using either a microorganism belonging to the species Aspergillus terreus or different microorganisms identified as species belonging to the Monascus genus.
- the isolation of the active ingredient is carried out either by extracting directly the fermentation liquor with a solvent or by extracting the filtered liquor and the biomass and subsequently purifying the crude product by chromatography.
- the main disadvantage of the extraction method resides in the fact that the solvent dissolves, together with the active ingredient, a lot of concomitant contaminations rendering thereby the further purification more complicated and expensive.
- the purification at a proper efficiency can be accomplished namely by a multistage column chromatographic method and subsequent re- crystallization.
- the present invention aims at providing a process for the isolation of mevinolin from fermentation liquor which can be carried out more readily and more economically than the hitherto known processes and enables the preparation of the active ingredient in a quality suitable for pharmaceutical purposes.
- the present invention is based on the recognition that the active ingredient can be separated at high efficiency directly from the filtrate of the fermentation liquor (hereinafter: filtered liquor) at a pH value between 4.5 and 1.0.
- the crude product separated in this manner does not require to be purified by chromatography, as only a surprisingly slight amount of contamination separates to ⁇ gether with it. Thus a simple recrystallization is sufficient to obtain a product of suitable quality.
- the active ingredient is dissolved from the biomass into the fermentation liquor at a pH value between 7.5 and 10.0, the biomass is filtered off, the crude product is separated from the filtered liquor at a pH value between 4.5 and 1.0 and purified by methods known per se, preferably by recrystallization.
- the separation of the active ingredient has been investigated at different acidic pH values.
- the pH range of 2.4 to 1.8, especially 2.2 to 2.0 has been found to be the most preferable.
- bivalent or trivalent metal salts such as alkaline earth metal salts (CaCl2, MgCl2, MgS04) or earth metal salts [ (AI2 (SO4)3] .
- Aliphatic alcohols having 1 to 4 carbon atom(s), glycols having 2 to 5 carbon atoms, secondary or tertiary amines having 1 to 3 carbon atom(s), alkyl acetates having 1 to 5 carbon atom(s), dimethyl-formamide, polyethylene glycol or polypropylene glycol may serve as additives.
- Additive Active ingredient content of the filtered liquor ( ⁇ g/cm )
- ethylene glycol and ethanol are particularly preferred.
- the additives effect their favourable activity even when applied in as slight amount as 0.1 % by volume calculated upon the volume of the fermentation liquor, and even when applied in greater amounts they do not have an influence on the separation of the dissolved active ingredient.
- the crude product can be purified by any known method, e.g. by a simple recrystallization. According to our experiments • it is preferable to carry out the re ⁇ crystallization from isobutyl acetate in such a manner that the solution of the substance in isobutyl acetate is washed with a weakly basic 2.5 w% ammonium sulfate solution adjusted to pH 8.5, the solvent phase is clarified with carbon, concentrated and the separated product is filtered off.
- the advantages of the process according to the present invention are as follows: it renders possible the elimination of the extraction of both the fermentation liquor and the biomass from the technological procedure, the active ingredient separated from the filtered liquor at an acidic pH value is surprisingly pure, so it does not require to be purified by chromatography, but a simple recrystallization results in a product suitable for pharmaceutical purposes. Consequently the technological procedure is simple and can be accomplished economically, with a slight loss of substance (with a yield of higher than 90 %) .
- the process according to the invention can be applied by starting from any aqueous fermentation liquor cultured by a microorganism bio-synthetizing mevinolin either as the open-chain hydroxy acid or as lactone.
- the filtered aqueous precipitate was dissolved in 50 cm of isobutyl acetate, the aqueous phase was separated and the solvent phase was concentrated to 2.5 cm .
- the concentrate was dissolved in 60 c ⁇ r of isobutyl acetate,
- the biomass was then filtered off and suspended in 400 c ⁇ r of water containing 0.8 g of ethylene glycol.
- the suspension was adjusted to a pH value between 8.5 and 9.0 with 20 wt% potassium hydroxide solution, filtered again and the filtrates were combined.
- Active ingredient content 99.7 % (HPLC).
- Dihydromevinolin content 0.15 % (GC)
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4395515T DE4395515T1 (en) | 1992-11-04 | 1993-09-08 | Process for the isolation and purification of mevinolin |
DE4395515A DE4395515C2 (en) | 1992-11-04 | 1993-09-08 | Process for the isolation and purification of mevinolin |
US09/578,587 US6812007B1 (en) | 1992-11-04 | 2000-04-19 | Process for the isolation and purification of mevinolin |
US10/842,221 US20060223150A1 (en) | 1993-09-08 | 2004-05-10 | Process for the isolation and purification of mevinolin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9203458A HU210867B (en) | 1992-11-04 | 1992-11-04 | Method for extraction and purification of mevinolin from culture medium |
HUP9203458 | 1992-11-04 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US26915094A Continuation | 1992-11-04 | 1994-06-30 | |
US26915094A Continuation-In-Part | 1992-11-04 | 1994-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994010328A1 true WO1994010328A1 (en) | 1994-05-11 |
Family
ID=10982513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/HU1993/000051 WO1994010328A1 (en) | 1992-11-04 | 1993-09-08 | Process for the isolation and purification of mevinolin |
Country Status (8)
Country | Link |
---|---|
AT (1) | AT401060B (en) |
CA (1) | CA2127381C (en) |
DE (2) | DE4395515T1 (en) |
ES (1) | ES2081776B1 (en) |
GR (1) | GR930100408A (en) |
HU (1) | HU210867B (en) |
IT (1) | IT1266672B1 (en) |
WO (1) | WO1994010328A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029292A1 (en) * | 1993-06-08 | 1994-12-22 | Krka Tovarna Zdravil P.O. | Process for the isolation of lovastatin |
WO1997020834A1 (en) * | 1995-12-06 | 1997-06-12 | Antibiotic Co. | Method of production of lovastatin |
WO2000063411A1 (en) * | 1999-04-16 | 2000-10-26 | Biotika A.S. | Process of isolation of lovastatin from fermentation broth |
EP1263979A1 (en) * | 2000-02-24 | 2002-12-11 | Biogal Gyogyszergyar Rt. | Method of purifying a fermentation broth |
EP1265884A1 (en) * | 2000-03-03 | 2002-12-18 | Biogal Gyogyszergyar Rt. | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2204285B1 (en) * | 2002-05-20 | 2005-03-01 | Ercros Industrial, S.A. | PROCEDURE FOR THE INSULATION AND PURIFICATION OF LOVASTATIN. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3006216A1 (en) * | 1979-02-20 | 1980-09-04 | Sankyo Co | NEW MONACOLIN K COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND |
DE3006215A1 (en) * | 1979-05-11 | 1980-11-27 | Sankyo Co | METHOD FOR PRODUCING MONACOLIN K |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR69216B (en) * | 1979-06-15 | 1982-05-07 | Merck & Co Inc | |
HU208997B (en) * | 1992-06-17 | 1994-02-28 | Gyogyszerkutato Intezet | Microbiological method for producing mevinoline |
-
1992
- 1992-11-04 HU HU9203458A patent/HU210867B/en not_active IP Right Cessation
-
1993
- 1993-09-08 CA CA002127381A patent/CA2127381C/en not_active Expired - Fee Related
- 1993-09-08 WO PCT/HU1993/000051 patent/WO1994010328A1/en not_active IP Right Cessation
- 1993-09-08 AT AT0901593A patent/AT401060B/en not_active IP Right Cessation
- 1993-09-08 ES ES09450018A patent/ES2081776B1/en not_active Expired - Fee Related
- 1993-09-08 DE DE4395515T patent/DE4395515T1/en active Pending
- 1993-09-08 DE DE4395515A patent/DE4395515C2/en not_active Expired - Fee Related
- 1993-10-18 GR GR930100408A patent/GR930100408A/en not_active IP Right Cessation
- 1993-11-04 IT IT93MI002343A patent/IT1266672B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3006216A1 (en) * | 1979-02-20 | 1980-09-04 | Sankyo Co | NEW MONACOLIN K COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND |
DE3006215A1 (en) * | 1979-05-11 | 1980-11-27 | Sankyo Co | METHOD FOR PRODUCING MONACOLIN K |
Non-Patent Citations (1)
Title |
---|
PROC. NATL. ACAD. SCI. U.S.A., Volume 77, No. 7, Published July 1980, (Baltimore, USA), A.W. ALBERTS et al., "Mevindin: A Highly Potent Competitive Inhibitor of Hydroxymethylglutaryl-Coenzyme A Reductase and a Cholesterol-Lowering Agent", pages 3957-3961. * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029292A1 (en) * | 1993-06-08 | 1994-12-22 | Krka Tovarna Zdravil P.O. | Process for the isolation of lovastatin |
US5712130A (en) * | 1993-06-08 | 1998-01-27 | Krka Tovarna Zdravil, P.O | Process for the isolation of lovastatin |
WO1997020834A1 (en) * | 1995-12-06 | 1997-06-12 | Antibiotic Co. | Method of production of lovastatin |
WO2000063411A1 (en) * | 1999-04-16 | 2000-10-26 | Biotika A.S. | Process of isolation of lovastatin from fermentation broth |
EP1263979A1 (en) * | 2000-02-24 | 2002-12-11 | Biogal Gyogyszergyar Rt. | Method of purifying a fermentation broth |
EP1263979A4 (en) * | 2000-02-24 | 2003-05-21 | Biogal Gyogyszergyar | Method of purifying a fermentation broth |
EP1265884A1 (en) * | 2000-03-03 | 2002-12-18 | Biogal Gyogyszergyar Rt. | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
EP1265884A4 (en) * | 2000-03-03 | 2003-05-21 | Plus Chemical S A | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
Also Published As
Publication number | Publication date |
---|---|
AT401060B (en) | 1996-06-25 |
CA2127381C (en) | 1997-12-23 |
DE4395515C2 (en) | 1999-06-17 |
CA2127381A1 (en) | 1994-05-11 |
HU210867B (en) | 1995-10-30 |
ATA901593A (en) | 1995-10-15 |
ITMI932343A0 (en) | 1993-11-04 |
IT1266672B1 (en) | 1997-01-09 |
ES2081776B1 (en) | 1996-10-16 |
ES2081776A1 (en) | 1996-03-01 |
GR930100408A (en) | 1994-07-29 |
ITMI932343A1 (en) | 1995-05-04 |
DE4395515T1 (en) | 1994-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6387258B1 (en) | Method of purifying statins from a fermentation broth | |
CZ283540B6 (en) | Lovastatin isolation process | |
HU212583B (en) | New process for producing potassium salt of clavulanic acid | |
WO1994029292A9 (en) | Process for the isolation of lovastatin | |
AU2001236543A1 (en) | Method of purifying a fermentation broth | |
EP1265604B1 (en) | Process for recovering statin compounds from a fermentation broth | |
US6825015B1 (en) | Process for the obtaining of HMG-COA reductase inhibitors of high purity | |
WO1994010328A1 (en) | Process for the isolation and purification of mevinolin | |
EP0005614A1 (en) | Lithium pseudomonate, process for its isolation and its hydrolysis | |
WO2005082910A1 (en) | Process for isolation of ergot alkaloids from ergot | |
US6812007B1 (en) | Process for the isolation and purification of mevinolin | |
US20060223150A1 (en) | Process for the isolation and purification of mevinolin | |
US20090156837A1 (en) | Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth | |
EP1673361B1 (en) | A method for the manufacture of lovastatin | |
CA2425882A1 (en) | Method of purifying pravastatin or its pharmacologically acceptable salt | |
US2898268A (en) | Acid purification of fumagillin | |
CN114133331A (en) | Method for recovering and obtaining high-purity pravastatin ester | |
RU2088586C1 (en) | Method of preparing clavulanic acid or its pharmaceutically acceptable salts or esters | |
EP1481674B1 (en) | Process for recovering statin compounds from a fermentation broth | |
CS239441B1 (en) | Method of isolation and separation of alkaloids of agroklavine and elymoklavine | |
EP1798214A1 (en) | Process for recovering statin compounds from a fermentation broth | |
BG62330B1 (en) | Method for lovastatin preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT CA DE ES US |
|
ENP | Entry into the national phase |
Ref document number: 1993 9015 Country of ref document: AT Date of ref document: 19940511 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 19939015 Country of ref document: AT |
|
ENP | Entry into the national phase |
Ref document number: 9450018 Country of ref document: ES Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 009450018 Country of ref document: ES Ref document number: P009450018 Country of ref document: ES Ref document number: 2127381 Country of ref document: CA |
|
RET | De translation (de og part 6b) |
Ref document number: 4395515 Country of ref document: DE Date of ref document: 19941201 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4395515 Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 9450018 Country of ref document: ES Kind code of ref document: A |
|
WWG | Wipo information: grant in national office |
Ref document number: 9450018 Country of ref document: ES Kind code of ref document: A |
|
WWX | Former pct application expired in national office |
Ref document number: 9450018 Country of ref document: ES Kind code of ref document: A |